Strawberries may be the most effective of commonly consumed berries at slowing the growth of some cancer cells, according to a recent study published in the Journal of Agriculture and Food Chemistry.
Researchers at the University of California, Los Angeles, tested extracts of six berries - strawberries, raspberries, black raspberries, blueberries, blackberries and cranberries - against human oral, breast, colon and prostate tumor cell lines in cell cultures. All the berry extracts slowed the cancer cell growth in each cell line studied, and this protective effect grew stronger as berry concentrations were increased. Strawberries were strongest against colon and oral cancers.
"The strongest California strawberry effects were seen against slowing the growth of two types of oral cancer cells and one type of colon cancer cells," said Navindra Seeram, assistant director of UCLA Center for Human Nutrition and lead author of the study, adding: "in colon cancer cells, strawberries were also found to be potent inducers of programmed cell death, called apoptosis, which is an important mechanism of cancer suppression."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze